Scenic Biotech, a pioneer in modifier therapies for severe diseases, appointed Roland W. Bürli, PhD, as Chief Scientific Officer (CSO), effective September 1, 2025. At Scenic, Bürli will oversee the ...

Scenic Biotech is advancing modifier therapy, a radical new approach to treating genetic disorders. Instead of targeting the primary disease-causing mutation, modifier therapy seeks to rebalance ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Kotlin was designed to bring more flexibility and flow to programming in the JVM. Here's an in-depth look at how Kotlin makes working with classes and objects easier and introduces coroutines to ...

Ocugen (NASDAQ:OCGN) has secured a $30M debt funding from Avenue Venture Opportunities Fund, L.P., a fund of Avenue Capital Group. The credit facility, which has a term of 4 years, provided $30M fully ...

com.surrealdb.SurrealException: Unable to convert object at com.surrealdb.ValueBuilder.convert([ValueBuilder.java:93](vscode-file://vscode-app/Applications/Cursor.app ...

Virion Therapeutics, LLC announced positive immunologic and continued safety and tolerability data, from the first-ever human study of its novel, first-in-class, checkpoint modifier immunotherapy, ...

Imagine you are an expert object-oriented Java developer who meticulously crafts code the way an artist cares for their masterpiece. You believe clean code is an absolute necessity. Classes with clear ...